Neuroleptics, also known as antipsychotics, are medications primarily used to manage behavioral symptoms like agitation, aggression, and psychosis in Alzheimer's disease and dementia patients. However, their use is controversial due to potential side effects such as sedation, increased risk of falls, and cognitive decline. Neuroleptics work by blocking dopamine receptors in the brain, which can help alleviate symptoms but may also worsen cognitive function in elderly individuals already vulnerable to cognitive impairment.
Recent guidelines emphasize cautious and limited use of neuroleptics, preferring non-pharmacological approaches first. Behavioral interventions, environmental modifications, and caregiver education are preferred strategies to manage challenging behaviors. When neuroleptics are prescribed, it is crucial to monitor their effects closely and consider the individual's overall health and specific needs. Balancing the benefits against potential risks remains essential in optimizing care for Alzheimer's and dementia patients.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China